Clinical Trial Detail

NCT ID NCT03050814
Title Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

colorectal cancer

Therapies

Bevacizumab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Capecitabine

Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine

Ad-CEA vaccine + Avelumab + Bevacizumab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.